The Massachusetts Life Sciences Center (MLSC) recently announced more than $15 million in capital funding to support life sciences innovation infrastructure, the development of key data repositories and training for scientists across the commonwealth.
In total, 17 projects are receiving funding to support the life sciences ecosystem, including three at UMass Medical School. The MLSC awarded funding through its Open Capital program to the UMass Medical School Positron Emission Tomography Center, led by Mary Rusckowski, PhD, associate professor of radiology; and the project Enhancing Innovation in Drug Discovery, by Paul Thompson, PhD, professor of biochemistry & molecular pharmacology and director of the Chemical Biology Interface program at the Medical School.
Through its Bits to Bytes program, the MLSC awarded funding to Christina Baer, PhD, assistant professor of microbiology & physiological systems, and Dorothy Schafer, PhD, assistant professor of neurobiology, and their industry partner, Tiaki, for the project Spatial Transcriptomic Approaches to Map Neuroinflammation in Neurodegenerative Disease.